Skip to content

Vinblastine

Velban (vinblastine) is a small molecule pharmaceutical. Vinblastine was first approved as Velban on 1982-01-01. It is used to treat breast neoplasms, choriocarcinoma, head and neck neoplasms, histiocytosis, and hodgkin disease amongst others in the USA. The pharmaceutical is active against tubulin beta chain.
Trade Name Velban
Common Name Vinblastine
Indication breast neoplasms, choriocarcinoma, head and neck neoplasms, histiocytosis, hodgkin disease, kaposi sarcoma, kidney neoplasms, lung neoplasms, mycosis fungoides, testicular neoplasms, thrombocytopenic purpura idiopathic
Drug Class Antihistaminics (histamine-H1 receptor antagonists); vinca alkaloids
Vinblastine
Get full access now